第四範式(06682.HK):擬回購不超10%H股股份
格隆匯4月8日丨第四範式(06682.HK)公佈,股東已於2024年6月20日審議通過一般性及無條件給予董事一般授權,即回購不超過已在聯交所發行之H股股份(不包括任何庫存股份)總數10%的H股股份(即不超過13,544,045股H股股份)。
基於對公司未來發展前景的堅定信心及內在價值的高度認可,切實維護公司全體股東權益,持續鞏固市場對本公司的信心,提升公司投資價值,於2025年4月8日,董事會決議行使回購股份授權,擬在公開市場以現有內部財務資源回購不超過回購股份授權之H股股份數。公司倘落實按如上計劃行使回購股份授權以回購H股股份時,將遵守公司章程、上市規則及其他適用法律法規。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.